Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New Cystic Fibrosis Drug Meets Trial Goal
Link ID 6484
Title New Cystic Fibrosis Drug Meets Trial Goal
Url http://www.medscape.com/viewarticle/575722?src=rss
Description A late-stage trial of denufosol, an inhaled cystic fibrosis drug, met the main study goal of significantly improving breathing, Inspire Pharmaceuticals Inc said Friday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jun 10, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Galvus Gets Positive EU Opinion
  Galvus (vildagliptin; Novartis), a dipeptidyl peptidase-IV (DPP-IV) inhibitor that improves cell responsiveness to glucose, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety concerns. Reuters Health Information
Category:   Articles > Business of Medicine


2. How Can I Avoid Clinical Mistakes?
  I am constantly worrying about making mistakes. Is there any way to minimize errors?
Medscape Med Students
Category:   Articles > Business of Medicine


3. Abiomed Says FDA Approves Circulatory Support System
  Medical device maker Abiomed Inc said U.S. health regulators approved its combination iPulse circulatory support system. Reuters Health Information
Category:   Articles > Business of Medicine


4. Coventry Health Profit up 3 Pct, Meets Estimates
  Coventry Health Care Inc posted a 3 percent first-quarter profit increase on Friday, matching Wall Street estimates, helped by higher membership, and the insurer backed its full-year forecast. Reuters Health Information
Category:   Articles > Business of Medicine


5. Targeting Cardiovascular Protection: The Concept of Dual Renin-Angiotensin System Control
  ACE inhibitor/ARB combination therapy for dual RAS control has the potential to effectively lower blood pressure and reduce the risk for cardiovascular events.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS